Dr. Michael Heinrich

Home/Tag: Dr. Michael Heinrich

LRG Webcast Series: New Treatment Options for Advanced GIST & Concerns about the Coronavirus

During this webcast presentation, Dr. Michael Heinrich will discuss these two new treatment options for advanced GIST. Dr. Heinrich will explain how each of these drugs works to target mutations for which there has previously been no targeted treatment and discuss the current coronavirus outbreak.

By |2020-07-09T17:38:29-04:00March 24th, 2020|Drug Treatment, GIST Education, Webcast|

One Perspective on the BLU-285 Trial (avapritinib/Ayvakit)

LRG members Jennifer & Owen Moore give their perspective on participating in the Phase I BLU-285 trial at OSHU with Dr. Michael Heinrich. After three other drug treatment lines and faced with several growing tumors, the BLU-285 (avapritinib) trial was Owen’s best option.

By |2020-03-09T10:18:42-04:00February 28th, 2020|D842V, News, Newsletter|

La Jolla Provided a Beautiful Backdrop for Our Three-Day July Event

The Life Raft Group and UCSD hosted a three-day event at University of California, San Diego UCSD-Moores Cancer Center from July 13th through July 15th. A GIST Awareness Day (GAD) event took place on July [...]

By |2019-08-01T10:07:21-04:00September 18th, 2017|Advocacy, Caregiver Support, Events, GDOL, GIST Education, News, Newsletter|

New Data Indicates Imatinib Boosts Long-Term Survival for Some GIST Patients

A significant finding from a newly published study in JAMA Oncology, indicates that nearly one-fourth of GIST patients with advanced disease initially treated with imatinib will survive for ten years or more. The study, [...]

By |2018-10-30T09:19:32-04:00February 27th, 2017|News, Research|

GIST Day of Learning: Education and Support for Area GISTers

The Life Raft Group kicked off its 2016 GIST Day of Learning (GDOL) series this spring with events from coast to coast. GDOLs are free, one-day programs that provide both education and support for the GIST [...]

By |2019-06-03T16:19:13-04:00June 10th, 2016|GIST Education, Newsletter|
Go to Top